Safety, Tolerability, and Metabolic Effects of Long-Acting Cabotegravir and Rilpivirine in HIV Care: A Comprehensive Review

The use of long-acting cabotegravir and rilpivirine (LA CAB/RPV) is a novel approach to manage human immunodeficiency virus (HIV). This injectable regimen offers benefits such as an improved quality of life, reduced stigma and enhanced treatment satisfaction by minimising the need for daily medicati...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Martina Bottanelli, Antonella Castagna, Camilla Muccini
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-08-01
Colecção:	Viruses
Assuntos:	long-acting cabotegravir rilpivirine antiretroviral therapy people with HIV safety
Acesso em linha:	https://www.mdpi.com/1999-4915/17/8/1108
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!